Mercnbeth -> RE: California to Vote on Legal Marijuana (1/14/2010 7:49:27 AM)
|
For those who don't think anything is being done or has been done to address the legality of cannabis (medicinally speaking or not) at the Federal level: quote:
Massachusetts Democrat Barney Frank, along with a bipartisan coalition of 13 co-sponsors, is seeking to strengthen legal protections for state-authorized medical marijuana patients. House Bill 2835, The Medical Marijuana Patient Protection Act of 2009, would ensure that medical cannabis patients in states that have approved its use will no longer have to fear arrest or prosecution from federal law enforcement agencies. Thirteen states -- Alaska, California, Colorado, Hawaii, Maine, Michigan, Montana, New Mexico, Nevada, Oregon, Rhode Island, Vermont and Washington -- have enacted laws protecting medical marijuana patients from state prosecution. Yet in all of these states, patients and providers still face the risk of federal sanction -- even when their actions are fully compliant with state law. It is time that we allowed our unique federalist system to work the way it was intended. Patients and their state representatives should have the authority to enact laws permitting the medical use of cannabis -- free from federal interference. Previous versions of The Medical Marijuana Patient Protection Act were introduced in both the 108th and 109th Congress, but failed to receive a public hearing or a committee vote. there are legislators that are attempting to reconcile the 13...now 14 with New Jersey...states that have medicinal laws with NEW federal policy concerning it. then there is this: quote:
...US Patent #6630507...Issued October 7, 2003 Assignnee: The United States of America as represented by the Department of Health & Human Services Abstract: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3. ##STR1##...PatentStorm Edited to add: (Merc) beth - my little political activist! I'm waiting for the notification for her testifying in front of Congress on this issue. Don't get her started!!
|
|
|
|